Information session on Harvard Medical School's Clinical Development Strategies

Learn More: https://emrt.us/HMS-CDLP-LearnMore-YT

Disruptive changes in the pharmaceutical industry landscape are opening up new approaches to optimize clinical trial strategy. This includes patient-centric study design and digital technologies to enhance clinical research, trial efficiency and revenue generation. Opportunity also exists for data science to revolutionize drug development and clinical trials, with insights from real-world data informing trial strategies, protocol design and exclusion criteria; however, rapid innovation has increased the complexity of trials and costly delays are common, placing unsustainable pressure on trial sites. Clinical development leaders must understand how technological advances like artificial intelligence can improve drug development, while finding solutions to diversity and equity in trials.

The 14-week Clinical Development Strategies: Beyond Clinical Trials program from Harvard Medical School Executive Education will equip you to address these challenges and unlock increased value in clinical development projects. Using the latest digital tools, frameworks and case studies taught by Harvard Medical School faculty and leading practitioners, you will learn to improve clinical trial design and performance as well as think beyond trial outcomes to facilitate the success of products throughout their development lifecycles.

You will also explore AI's impact on clinical workflows and health care transformation. This includes examining its strategic implications and addressing AI adoption considerations, including feasibility, integration challenges and stakeholder engagement, considering both short-and long-term organizational needs.

Видео Information session on Harvard Medical School's Clinical Development Strategies канала Emeritus